RHY — Rhythm Biosciences Balance Sheet
0.000.00%
Last trade - 00:00- AU$18.72m
- AU$14.42m
- AU$0.05m
Annual balance sheet for Rhythm Biosciences, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | AAS | AAS | AAS | AAS | AAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1.84 | 2.27 | 7.6 | 4.17 | 0.754 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.139 | 0.164 | 0.081 | 0.066 | 0.037 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2.01 | 2.49 | 7.77 | 7.12 | 0.887 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.103 | 0.114 | 0.07 | 0.105 | 0.113 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 2.65 | 3.07 | 8.44 | 7.7 | 1.52 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.794 | 1.34 | 0.932 | 1.77 | 0.562 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.803 | 1.36 | 1.07 | 1.82 | 0.652 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 1.84 | 1.71 | 7.37 | 5.87 | 0.867 |
| Total Liabilities & Shareholders' Equity | 2.65 | 3.07 | 8.44 | 7.7 | 1.52 |
| Total Common Shares Outstanding |